On the Homocysteine issue,
Prof Reynolds rightly stated --
"But a causal relationship between homocysteine and CHD was assumed and clinical trials of reducing homocysteine by vitamin therapy (e.g. NOR-VIT) have not shown any benefit of homocysteine reduction. So, evidence of a possible causal relationship must be treated with extreme caution."
___
While this is true, perhaps all the study was really showing was that the damage to vessel walls by homocysteine had already been done and was not reversible. A causal relationship has not been fully discounted.
Greg Watts (M.Sc. M.A.)
Deputy Director - Pathology
Sydney Adventist Hospital
[log in to unmask] <mailto:[log in to unmask]>
_________________________________________________________________________
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|